rs35303786

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_198578.4(LRRK2):​c.4937T>C​(p.Met1646Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0142 in 1,611,888 control chromosomes in the GnomAD database, including 220 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M1646V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.010 ( 14 hom., cov: 33)
Exomes 𝑓: 0.015 ( 206 hom. )

Consequence

LRRK2
NM_198578.4 missense

Scores

2
2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 5.68

Publications

62 publications found
Variant links:
Genes affected
LRRK2 (HGNC:18618): (leucine rich repeat kinase 2) This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008]
LRRK2 Gene-Disease associations (from GenCC):
  • autosomal dominant Parkinson disease 8
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • Parkinson disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary late onset Parkinson disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003975332).
BP6
Variant 12-40320097-T-C is Benign according to our data. Variant chr12-40320097-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 39200.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0103 (1564/152200) while in subpopulation NFE AF = 0.0158 (1073/67958). AF 95% confidence interval is 0.015. There are 14 homozygotes in GnomAd4. There are 728 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1564 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRRK2NM_198578.4 linkc.4937T>C p.Met1646Thr missense_variant Exon 34 of 51 ENST00000298910.12 NP_940980.4 Q5S007Q17RV3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRRK2ENST00000298910.12 linkc.4937T>C p.Met1646Thr missense_variant Exon 34 of 51 1 NM_198578.4 ENSP00000298910.7 Q5S007

Frequencies

GnomAD3 genomes
AF:
0.0103
AC:
1564
AN:
152082
Hom.:
14
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00256
Gnomad AMI
AF:
0.0493
Gnomad AMR
AF:
0.0104
Gnomad ASJ
AF:
0.0222
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.00480
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0158
Gnomad OTH
AF:
0.0173
GnomAD2 exomes
AF:
0.00937
AC:
2340
AN:
249600
AF XY:
0.00946
show subpopulations
Gnomad AFR exome
AF:
0.00227
Gnomad AMR exome
AF:
0.00408
Gnomad ASJ exome
AF:
0.0208
Gnomad EAS exome
AF:
0.0000545
Gnomad FIN exome
AF:
0.00389
Gnomad NFE exome
AF:
0.0153
Gnomad OTH exome
AF:
0.00906
GnomAD4 exome
AF:
0.0146
AC:
21383
AN:
1459688
Hom.:
206
Cov.:
34
AF XY:
0.0143
AC XY:
10377
AN XY:
726152
show subpopulations
African (AFR)
AF:
0.00195
AC:
65
AN:
33324
American (AMR)
AF:
0.00477
AC:
212
AN:
44468
Ashkenazi Jewish (ASJ)
AF:
0.0216
AC:
562
AN:
26066
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39630
South Asian (SAS)
AF:
0.00362
AC:
311
AN:
85912
European-Finnish (FIN)
AF:
0.00474
AC:
253
AN:
53384
Middle Eastern (MID)
AF:
0.00852
AC:
49
AN:
5754
European-Non Finnish (NFE)
AF:
0.0172
AC:
19065
AN:
1110836
Other (OTH)
AF:
0.0143
AC:
864
AN:
60314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1040
2080
3119
4159
5199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
730
1460
2190
2920
3650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0103
AC:
1564
AN:
152200
Hom.:
14
Cov.:
33
AF XY:
0.00978
AC XY:
728
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.00255
AC:
106
AN:
41568
American (AMR)
AF:
0.0104
AC:
158
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.0222
AC:
77
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00352
AC:
17
AN:
4824
European-Finnish (FIN)
AF:
0.00480
AC:
51
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0158
AC:
1073
AN:
67958
Other (OTH)
AF:
0.0171
AC:
36
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
80
161
241
322
402
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0137
Hom.:
36
Bravo
AF:
0.0110
TwinsUK
AF:
0.0186
AC:
69
ALSPAC
AF:
0.0176
AC:
68
ESP6500AA
AF:
0.00341
AC:
15
ESP6500EA
AF:
0.0154
AC:
132
ExAC
AF:
0.00909
AC:
1103
Asia WGS
AF:
0.00145
AC:
6
AN:
3472
EpiCase
AF:
0.0158
EpiControl
AF:
0.0171

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 21, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25821816, 21885347, 24470158, 23913756) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 07, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant Parkinson disease 8 Benign:2Other:1
Mar 08, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

LRRK2-related disorder Benign:1
Nov 27, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
21
DANN
Benign
0.93
DEOGEN2
Benign
0.25
T
Eigen
Benign
0.013
Eigen_PC
Benign
0.20
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.67
T
MetaRNN
Benign
0.0040
T
MetaSVM
Benign
-0.80
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
5.7
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.18
Sift
Benign
0.16
T
Sift4G
Pathogenic
0.0010
D
Polyphen
0.0010
B
Vest4
0.39
MVP
0.86
MPC
0.10
ClinPred
0.023
T
GERP RS
5.7
Varity_R
0.57
gMVP
0.45
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35303786; hg19: chr12-40713899; COSMIC: COSV100111542; COSMIC: COSV100111542; API